CVC Seeks Co-Investor for Recordati Acquisition

Private equity firm CVC Capital Partners is seeking a co-investor to finance its acquisition offer for Italian pharmaceutical manufacturer Recordati. The deal is valued at €10.9 billion. Sources close to the matter report that CVC is in talks with capital partners to fund this large-scale transaction. The deal stands out as one of the significant transactions in the European pharmaceutical sector. The acquisition of Recordati reflects the recent trend of increasing large-scale deals in the private equity sector. CVC's search for a co-investor is seen as part of a strategy to share risk and alleviate financial burden. The completion of the transaction could accelerate consolidation moves in the European healthcare sector. Details of the financing structure and the identity of potential partners have not yet been disclosed to the public. Market observers note that such large-scale private equity deals are an indicator of investment appetite in the sector. The timing and final terms of the deal will be shaped by the negotiations of the relevant parties. Not investment advice.